Submission Period: Submissions are possible online through our dedicated submission page only from 18 OCTOBER

Online submission: from 18 October 2016

Submission deadline: 10 April 2017


SUBMIT YOUR ABSTRACTS ONLINE - CLICK HERE
STEP 1: ABSTRACT INFORMATION

Title: Maximum 200 characters typed in lower-case letters, except for abbreviations and study names. Please double check the title once you have completed the information as it could have been truncated when copying and pasting it into the field.

Topic: Select one topic from the list which best describes the content. Make sure you select the appropriate topic as this choice will determine who will review your abstract.

LIST OF TOPICS – Suggested abstract topics

(Please note that this is not an exhaustive list of topics and, in addition to those listed below, other subjects linked to cardiovascular pharmacotherapy will be considered to be acceptable for submission for grading)

  • Cardiovascular disease prevention
  • Management of hypertension
  • Treatment of heart failure
  • Management of arrhythmias
  • Management of coronary artery disease
  • Management of angina pectoris
  • Antithrombotic and anticoagulant therapy
  • Lipid lowering agents
  • Pharmacology issues
On behalf of: You may use this field to enter the name of the affiliation for your research.

Category: You must select one of the following categories under which your abstract can best be classified:

  • BENCH: Animal studies or in vitro experiments at the molecular, cellular or tissue level (including human tissue). The core data is generated in the lab.
  • BEDSIDE: Patient studies. The core data is generated during clinical studies or interventions.
Options:  EURO CVP YOUNG RESEARCHER SUPPORT PROGRAMME

The programme is open to researchers under 40 years. The ESC Working Group on Pharmacotherapy (thanks to unconditional support from industry) will provide 1 free registration for each abstract chosen as part of the programme. The presenter must be under 40 and selected entries will be presented during the main session programme in the plenary hall in front of an international panel of experts. All abstracts will also be considered for the EURO CVP YOUNG RESEARCHER AWARD (see below for details).

Special note to submitters – If you are submitting the abstract on behalf of the first author/presenter, you must enter the first author’s birth date, as this date will be the qualifying point for the option validation.

Abstracts with non-eligible birth dates will be automatically removed from this section.

Please tick the appropriate box in the Abstract Information section. If your abstract is selected for a poster session, you will receive specific instructions. Prizes will be given to the three best presentations in each session during the Awards Ceremony.  A diploma for each winner and a cheque of €500 for the overall winner and €200 for each runner-up.*

Only the presenter will receive the award and diploma.

NB! When submitting an abstract for the EURO CVP YOUNG RESEARCHER SUPPORT PROGRAMME, the first prize winner commits to submitting the full manuscript pertaining to the presented research for consideration for publication in one of the ESC Journals (European Heart Journal or Cardiovascular Research).

STEP 2: ABSTRACT AUTHORS AND INSTITUTIONS

Your abstract must list at least 1 author in order to be submitted.

Authors list: Please note that the first author should be the abstract presenter by default.

In all cases, the presenter must be part of the authors list included in the submitted abstract. You may enter up to 10 authors in the authors list including the presenter. The names of authors will be published as listed on the submission form. Please make sure the information given for each author is correct, as no changes will be possible after the abstract is submitted (see paragraph on changes and corrections above).

If none of the authors are able to present the abstract during the congress, the abstract should be withdrawn. If not, it will be considered as no-show. In such cases the Congress Programme Committee reserve the right not to consider an abstract submitted by the same author the following year.

Institutions: This is a mandatory step.

You will be requested to advise us of your institution when you create the presenter and the authors.

ABSTRACT RESULTS

All abstracts will be reviewed by members of the Abstract Review Committee (graders). The final selection will be made by the ESC Working Group Congress Programme Committee on 1st March 2017.

All accepted abstracts will be scheduled as either 15 minutes oral presentations or half day Poster Presentations. The Congress Programme Committee will determine the format, day and time of presentation. For more information about the abstract sessions and scientific programme, please go to www.eurocvp.com and look under the Scientific Programme section.

An email message will be sent to the Abstract Submitter by 2nd March 2017 with a report on the status of the abstract (accepted or rejected).  If the abstract is accepted, instructions concerning the presentation will be given online when you submit your agreement form.

The same presenter cannot be assigned to more than 3 abstracts – co-authors should then be assigned as presenters.

Submission of an abstract constitutes a commitment by the author(s) to present if accepted. Failure to present and register for the Congress, if not justified, may jeopardize future acceptance of abstracts.

PUBLICATION OF ABSTRACTS AND EMBARGO

Until presentation at EURO CVP 2017 CONGRESS, accepted abstracts should not be published in any other journals and/or online publications or presented at any international congresses.

Submitting or presenting published work may jeopardize future acceptance of abstracts.

  • By submitting your work to the ESC, you consent to have authors’ names, affiliation and biographical material being used in connection with the publication of your work.
  • Author(s) represents and warrants that he/she/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.
  • The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.
  • Submitted abstracts should not have been published in any other journals and/or online publications nor presented at any previous international congress. However, former presentation at national meetings does not disqualify.
  • An author submitting or presenting published work may jeopardize future acceptance of abstracts.
  • The content belongs to the author(s). However if the abstract is accepted the submitter agrees, on behalf of all co-authors, to transfer and assign to the ESC the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press releases. This includes use in indexes or search databases in print, electronic, or other media.
  • Author(s) retain the right, after presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors or edits provided said use does not imply the endorsement of the ESC.

The submitter signs for all co-authors. He/She accepts responsibility on the present rules for submission and presentation on behalf of all co-authors.

CONFLICT OF INTEREST

The Congress Programme Committee requests all presenters to disclose potential conflict of interest. Oral abstract Presenters are requested to disclose potential conflicts of interest regarding their presentation in the first slide. Poster presenters are requested to disclose potential conflicts of interest regarding poster presentation at the bottom of their poster. This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.

DATA PRIVACY

By certifying that you have read these Submission rules, you also confirm having received the prior approval from the co-authors to provide their data to the ESC Working Group. You have personal data, which is,  according the Law on data processing and Civil Liberties 78-17 of 6 January 1978 modified, registered with the  European Society of Cardiology (ESC). The information you supply on this application is required to process it and it will be held in the ESC customer data files. It may be used for marketing and communication purposes by the ESC and its contractors only. You have the absolute right to access, amend and oppose any use of this personal data by writing to the ESC at the address mentioned below.

*Cheques will be sent to the winner on receipt of an invoice. Should the prize winner not be able to provide a regular invoice for the payment the EURO CVP secretariat will complete a “ritenuta d’acconto” request subtracting 20% from the cash amount, as required by Italian Tax law.